SecBot SecBot
8-K ·Filed Oct 29, 2026

MMSI

MERIT MEDICAL SYSTEMS INC
BULLISH
Impact 6/10
Horizonweeks Processed3d 2h ago SEC0000856982-26-000051
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised guidance midpoint implies Q4 2026 non-GAAP EPS of ~$1.08-$1.12, suggesting continued momentum. The Solo Pace acquisition is small (~0.8% of market cap) but strategically expands the structural heart portfolio; integration risk is low given the existing distribution relationship. Watch for Q4 2026 results and any update on the longer-term strategic plan mentioned in the CEO commentary.

DirectionBullish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Merit Medical reported Q3 2026 revenue of $416.2M (up 8.4% YoY) and GAAP EPS of $0.70 (up 51% YoY), exceeding consensus estimates of $410.6M and $1.04 non-GAAP EPS. The company raised full-year 2026 guidance: revenue to $1.635-$1.642B and non-GAAP EPS to $4.33-$4.37, reflecting stronger-than-expected organic growth of 9% constant currency. Separately, Merit acquired Solo Pace for ~$45M in cash, expanding its cardiac therapies platform with TAVR pacing technology.

Key Financial Metrics

EPS (Adj.)
$1.12
est $1.04 · +7.7% · GAAP: $0.70
Revenue
$416.2M
est $410.6M · +1.4% · +8.4% YoY
Rating
beat
Guidance
$1.635B-$1.642B
raised
Free Cash Flow
$129.5M
Gross Margin
48.2%

Key Facts

  • Q3 2026 reported revenue of $416.2M, up 8.4% YoY from $384.2M
  • GAAP EPS of $0.70, up 51% from $0.46 in Q3 2025
  • Non-GAAP EPS of $1.12, up 22% from $0.92 in Q3 2025
  • Organic constant currency revenue growth of 8.9% in Q3 2026
  • GAAP operating margin improved to 14.1% from 11.1% in Q3 2025
  • Non-GAAP operating margin improved to 21.3% from 19.7% in Q3 2025
  • Full-year 2026 revenue guidance raised to $1.635-$1.642B (prior $1.631-$1.643B)
  • Full-year 2026 non-GAAP EPS guidance raised to $4.33-$4.37 (prior $4.25-$4.35)
  • Acquired Solo Pace on October 13, 2026 for ~$45M cash
  • Cash and cash equivalents of $503.6M as of September 30, 2026
  • Total debt of $747.5M unchanged from year-end 2025

Financial Impact

Revenue beat consensus by ~$5.6M (1.4%); non-GAAP EPS of $1.12 vs consensus $1.04 (7.7% beat); guidance raised by $0.08-$0.02 at midpoint for non-GAAP EPS

revenueepsoperating marginguidance

Segment Breakdown

SegmentRevenueGrowth
Foundational$275.7M+6.0%
Therapeutic$140.5M+14.0%

Risk Factors

  • GAAP gross margin declined to 48.2% from 48.5% in Q3 2025
  • Non-GAAP gross margin declined to 52.8% from 53.6% in Q3 2025
  • Operating cash flow year-to-date of $175.2M is down from $198.9M in the prior year period
  • Free cash flow year-to-date of $129.5M is down from $141.6M in the prior year period
  • Solo Pace acquisition integration and revenue contribution uncertainty

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000856982-26-000051
Document: mmsi-ex99d2.htm0000856982-26-000051
Document: mmsi-20261029x8k.htm0000856982-26-000051
Document: mmsi-ex99d3.htm0000856982-26-000051
Document: 0000856982-26-000051-index-headers.html0000856982-26-000051
Document: 0000856982-26-000051-index.html0000856982-26-000051
Document: 0000856982-26-000051.txt0000856982-26-000051
8-K Data (Synthetic)0000856982-26-000051
11 reports for MMSI
Performance horizon
75% Hit rate @ T+60 3 of 4 directional calls Went positive at some point 3 of 4 best @ T+60▲ +37.91%May 5, 2026
Filters
Rows
Reports for MMSI, sortable and filterable
TypeNow
Oct 29, 2026
3d ago
8-K
BULLISH ★ 6/10
No priceawaiting T+60awaiting T+60No price
Oct 29, 2026
3d ago
Press Release
BULLISH ★ 6/10
$93.39awaiting T+60awaiting T+60$86.24 (−7.66%)
Oct 29, 2026
3d ago
Press Release
NEUTRAL ★ 4/10
$93.39awaiting T+60awaiting T+60$86.24 (−7.66%)
Oct 27, 2026
4d ago
Institutional Cluster
MIXED ★ 4/10
$92.21awaiting T+60awaiting T+60$86.24 (−6.47%)
Jul 2, 2026
17w ago
Press Release
NEUTRAL ★ 1/10
$71.09 $87.00▲ +22.38%▲ +18.81%$86.24 (+21.31%)
May 5, 2026
25w ago
Insider Cluster
NEUTRAL ★ 3/10
$60.44 $83.35▲ +37.91%▲ +35.17%$86.24 (+42.69%)
May 5, 2026
25w ago
Insider Cluster
BULLISH ★ 6/10
$60.44 $83.35▲ +37.91%▲ +35.17%$86.24 (+42.69%)
Apr 30, 2026
26w ago
Press Release
BULLISH ★ 7/10
$62.01 $78.29▲ +26.25%▲ +23.18%$86.24 (+39.07%)
Apr 16, 2026
28w ago
Court Ruling
BULLISH ★ 6/10
$70.10 $73.26▲ +4.51%▼ −2.54%$86.24 (+23.02%)
Apr 13, 2026
28w ago
8-K
NEUTRAL ★ 3/10
$70.54 $71.46▲ +1.30%▼ −7.22%$86.24 (+22.26%)
Showing 10 of 11

US Market Status

Market Closed · Opens Mon (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026